Ashley Cobert
Medical · Scottsdale, AZNPI 1346648839
Payments from drug & device makers
Across 262 payments — averaging $19.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$1K
- BETA Bionics, Inc.$407
- Novo Nordisk$401
- Dexcom, Inc.$307
- Boehringer Ingelheim$237
- Corcept Therapeutics$203
- plus $2K from 33 others
What the payments were for
- Food & beverage$5,158100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 57 | $1,126 |
| BETA Bionics, Inc. | 31 | $407 |
| Novo Nordisk | 19 | $401 |
| Dexcom, Inc. | 15 | $307 |
| Boehringer Ingelheim | 6 | $237 |
| Corcept Therapeutics | 11 | $203 |
| Amgen(2 entities) | 11 | $186 |
| Radius Health, Inc. | 9 | $186 |
| AstraZeneca(2 entities) | 9 | $170 |
| Sequel Med Tech, LLC | 2 | $153 |
| Xeris Pharmaceuticals, Inc. | 8 | $150 |
| AbbVie | 8 | $145 |
| Amneal Pharmaceuticals LLC | 8 | $144 |
| Antares Pharma, Inc. | 8 | $140 |
| Abbott | 6 | $137 |
| Intuity Medical Inc | 2 | $131 |
| Bayer | 8 | $119 |
| Sanofi-aventis U.S. LLC | 6 | $94 |
| Insulet Corporation | 6 | $93 |
| Tandem Diabetes Care, Inc. | 4 | $64 |
| Medtronic | 3 | $59 |
| Halozyme Inc | 3 | $55 |
| Kyowa Kirin, Inc. | 2 | $54 |
| Amryt Pharma Holdings Ltd | 2 | $48 |
| Astellas Pharma US Inc | 2 | $43 |
| Mannkind Corporation | 2 | $37 |
| Amphastar Pharmaceuticals, Inc. | 2 | $33 |
| Sandoz | 1 | $31 |
| Cequr Corporation | 1 | $27 |
| Chiesi USA, Inc. | 1 | $24 |
| Ascensia Diabetes Care US Inc. | 1 | $24 |
| Zealand Pharma US, Inc. | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| Averitas Pharma Inc. | 1 | $20 |
| Tolmar, Inc. | 1 | $18 |
| Ionis Pharmaceuticals, Inc. | 1 | $17 |
| Boston Scientific | 1 | $16 |
| Verity Pharmaceuticals Inc. | 1 | $15 |
| Clarus Therapeutics Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,169 in reported general payments places this provider in the 85th percentile of 748 medical providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 265 | $375,655 |
| Tresiba Flextouch U-200Insulin Degludec | 103 | $154,284 |
| TrulicityDulaglutide | 53 | $90,493 |
| JardianceEmpagliflozin | 76 | $84,865 |
| MounjaroTirzepatide | 44 | $72,289 |
| Tresiba Flextouch U-100Insulin Degludec | 50 | $32,114 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 23 | $24,311 |
| FarxigaDapagliflozin Propanediol | 24 | $16,608 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $16,009 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 19 | $13,732 |
| HumalogInsulin Lispro | 35 | $12,531 |
| Humalog Kwikpen U-100Insulin Lispro | 40 | $12,314 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 16 | $12,009 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 96 | $11,361 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 27 | $10,128 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Tresiba | $401 | $379,942278 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Humalog | $1,126 | $175,312132 claims |
| Boehringer IngelheimJardiance | $237 | $84,86576 claims |
| AstraZenecaFarxiga | $170 | $16,60824 claims |
| AbbVieSynthroid | $145 | $5,50664 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $144 | $3,311291 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 748 medical providers in Arizona.
Other medical in Scottsdale
- Robert CasquejoScottsdale$474K
- Darren WestScottsdale$206K
- Jamie WystrachScottsdale$79K
- Kendall JensonScottsdale$39K
- Ann Marie ChavezScottsdale$23K
- Emma ReeveScottsdale$15K
- Fiona BluntScottsdale$12K
- Francine MartynScottsdale$10K
- Victoria CarpenterScottsdale$9K
- Andrew HicksPeoria$460K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.